Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis (Q66545999)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis |
clinical trial |
Statements
CLARITY (English)
0 references
A 52-week, Randomized, Double-blind Study of Secukinumab (300 mg) Compared to Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis (English)
0 references
22 June 2016
0 references
9 July 2018
0 references
1,114
0 references
18 year
0 references